welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
John L. Jefferies, MD, MPH, FACC, FAHA, FHFSA
University of Tennessee Health Science Center
A312 Coleman Building
956 Court Avenue
Memphis, Tennessee, United States
In 2018, John L. Jefferies has been appointed the Jay M. Sullivan Endowed Chair in Cardiovascular Medicine and Chief of Cardiology at the University of Tennessee Health Science Center (UTHSC). He has also been named co-director for UT Methodist Institute for Cardiovascular Science.
Dr. Jefferies graduated from UT Knoxville with a degree in microbiology in 1992 and acquired his medical degree from UTHSC in 1996. He then completed an internship and residency in internal medicine and pediatrics at the University of Kentucky followed by adult and pediatric cardiology (combined) training at Baylor College of Medicine in Houston, TX. Dr. Jefferies has served for more than eight years at the University of Cincinnati College of Medicine and Cincinnati Children’s, where he was an associate professor of adult cardiovascular disease and pediatric cardiology from 2010-2015, professor of adult cardiovascular disease and pediatric cardiology from 2015-2018, and professor of human genetics from 2015-2018.
His research interests include novel gene discovery for various forms of cardiomyopathy, quality-of-life research in cardiomyopathy and heart failure, cardio-oncology, cardiac care in genetic syndromes, and novel drug investigation in heart failure.
other Duchenne content
Raising Both Dystrophin and Utrophin Levels May Rescue Muscles in DMD, Mouse Study SuggestsUsing a genetic engineering tool to rest...
New CRISPR technique skips over portions of genes that can cause diseaseIn a new study in cells, researchers hav...
Sarepta Therapeutics Announces that Phase 1/2a Duchenne Muscular Dystrophy (DMD) Micro-Dystrophin Gene Therapy Trial...Sarepta Therapeutics, Inc., a commercia...
Sarepta Therapeutics Statement on ICER Draft Evidence Report for Treatments for Duchenne Muscular DystrophySarepta Therapeutics, Inc., the leader...
Differences in cardiac involvement between carriers of Duchenne and Becker muscular dystrophy – a cardiovascul...Background Duchenne (DMD) and Becker (B...
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular DystrophyThe main purpose of this study is to tes...
Solid Biosciences Reports First Quarter 2019 Financial Results and Provides Business UpdateSolid Biosciences Inc. (Nasdaq: SLDB) to...